Reckitt Benckiser Group (OTCMKTS:RBGLY) Upgraded by Zacks Research to Hold Rating

Zacks Research upgraded shares of Reckitt Benckiser Group (OTCMKTS:RBGLY) from a strong sell rating to a hold rating in a research report sent to investors on Monday,Zacks.com reports.

A number of other research firms have also recently weighed in on RBGLY. Morgan Stanley raised shares of Reckitt Benckiser Group from an “equal weight” rating to an “overweight” rating in a report on Monday, March 16th. Kepler Capital Markets raised shares of Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a report on Friday, April 17th. Two research analysts have rated the stock with a Strong Buy rating, two have assigned a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy”.

Reckitt Benckiser Group Stock Performance

Shares of Reckitt Benckiser Group stock opened at $12.54 on Monday. The company has a debt-to-equity ratio of 0.98, a current ratio of 0.85 and a quick ratio of 0.63. The firm has a fifty day moving average price of $12.92 and a 200 day moving average price of $14.90. Reckitt Benckiser Group has a 1 year low of $12.02 and a 1 year high of $17.80.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc is a multinational consumer goods company that develops, manufactures and markets health, hygiene and home products. Its portfolio spans over-the-counter medicines and health products, personal and sexual wellness, surface and laundry cleaning, and household care. The company owns a number of well-known global brands across these categories, including Lysol and Dettol in disinfectants and hygiene, Durex in sexual wellness, Nurofen in analgesics, and Finish in dishwashing products.

The firm has its corporate headquarters in the United Kingdom and sells products in markets around the world, serving consumers across North America, Europe, Asia, Latin America, the Middle East and Africa.